Antibiotics use for URTI and ENT diseases | Baseline (12 months prior to study start) | 3rd FU Visit (months 1-3 of post-treatment) | Termination Visit (months 4-6 of post-treatment) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
CalSuli-4-02 group N = 99 | Control group N = 101 | CalSuli-4-02 group N = 99 | Control group N = 101 | CalSuli-4-02 group N = 99 | Control group N = 101 | |||||||
N | % | N | % | N | % | N | % | N | % | N | % | |
Always | 18 | 18.2 | 11 | 10.9 | 2 | 2.0 | 8 | 7.9 | 2 | 2.0 | 5 | 5.0 |
Sometimes | 34 | 34.3 | 42 | 41.6 | 7 | 7.1 | 12 | 11.9 | 5 | 5.1 | 12 | 11.9 |
Seldom | 27 | 27.3 | 35 | 34.7 | 14 | 14.1 | 12 | 11.9 | 8 | 8.1 | 4 | 4.0 |
Never | 20 | 20.2 | 12 | 11.9 | 65 | 65.7 | 53 | 52.5 | 65 | 65.7 | 60 | 59.4 |
Missing | 0 | 0.0 | 1 | 1.0 | 11 | 11.1 | 16 | 15.8 | 19 | 19.2 | 20 | 19.8 |